Herbal

Luteolin

Also known as: 3',4',5,7-tetrahydroxyflavone, LUT

Overview

Luteolin is a naturally occurring flavonoid found in various plants and foods, such as celery, peppers, and chamomile, with emerging evidence supporting its neuroprotective, anti-inflammatory, and antioxidant properties. Pre-clinical studies indicate that luteolin modulates key cellular pathways involved in neurodegenerative diseases, including Alzheimer’s and Parkinson’s, by reducing neuroinflammation, scavenging reactive oxygen species, and protecting mitochondrial function. It promotes mitochondrial biogenesis, enhances ATP production, and induces mitophagy, suggesting a role in maintaining neuronal energy homeostasis and preventing neurodegeneration [1][4][5]. Luteolin has also been investigated as an adjunct in viral infections like COVID-19 due to its immunomodulatory effects [7]. However, concerns exist regarding its endocrine-disrupting potential, with evidence showing it acts as a progesterone antagonist and estrogen agonist, which may pose risks in hormone-sensitive conditions [2]. Despite promising mechanistic data, clinical evidence in humans remains limited, and optimal dosing has not been established through rigorous phase II trials [7][3].

Dosage Guide

Therapeutic Doses

For treatment of specific conditions

Neuroprotection (pre-clinical models)50-100 mg/dayBased on animal and in vitro studies; human efficacy not confirmed
Anti-inflammatory/immunomodulation100 mg twice dailyUsed in experimental settings; limited human data

Research

Key FindingsPubMed
1

Luteolin shows promise in targeting multiple signaling pathways in Alzheimer's and Parkinson's disease models, with strong neuroprotective potential.

Luteolin: Nature's promising warrior against Alzheimer's and Parkinson's disease.
Journal of biochemical and molecular toxicology2024
2

Luteolin acts as a progesterone antagonist and potent estrogen agonist, indicating endocrine-disrupting activity.

Endocrine disrupting activities of the flavonoid nutraceuticals luteolin and quercetin.
Hormones & cancer2013
3

Highlights the risk of skipping phase II dose-finding trials when developing dietary supplements, which applies to luteolin's clinical development.

Clinical development of dietary supplements: the perils of starting at phase III.
Fitoterapia2011
4

Reviews luteolin's anti-inflammatory, antioxidant, and neuroprotective effects in neurodegenerative disease models.

Luteolin for neurodegenerative diseases: a review.
Pharmacological reports : PR2024
5

Demonstrates luteolin's modulation of mitochondrial function, including biogenesis, fission/fusion, and OXPHOS improvement.

Pre-clinical evidence for mitochondria as a therapeutic target for luteolin: A mechanistic view.
Chemico-biological interactions2025
6

Reviews potential toxicity of flavonoids, including understudied safety profiles despite widespread supplement use.

[Advances in studies on potential toxicity of flavonoids].
Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica2006
7

Suggests luteolin may support immune response and symptom improvement in COVID-19 as part of nutraceutical combinations.

Can nutraceuticals assist treatment and improve covid-19 symptoms?
Natural product research2022
8

Discusses lack of robust clinical evidence for many dietary supplements, including flavonoids, for chronic disease prevention.

Dietary supplements and cardiovascular disease.
Current atherosclerosis reports2000

Products Containing Luteolin(1 report)